| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | WO2009137133A3 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
| 01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
| 01/21/2010 | US20100016550 Methods for Site-Specific Pegylation |
| 01/21/2010 | US20100016388 Salts of a Selective Beta-2 Andrenoceptor Agonist |
| 01/21/2010 | US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties |
| 01/21/2010 | US20100016304 Glucokinase activator |
| 01/21/2010 | US20100016260 Agonists of sphingosine-1 phosphate receptor (slp) |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | CA2731097A1 Organic compounds |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730749A1 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | CA2729212A1 Compounds and methods for modulating g protein-coupled receptors |
| 01/21/2010 | CA2728636A1 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 01/21/2010 | CA2727674A1 Process for making substituted 2-amino-thiazolones |
| 01/20/2010 | EP2144879A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof |
| 01/20/2010 | EP1968957B1 Substituted thiazoles and their use for producing drugs |
| 01/20/2010 | EP1633730B1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
| 01/20/2010 | EP1555257B1 Process for producing aromatic nitrile compound |
| 01/20/2010 | EP1513818B1 Heterocyclic inhibitors of vegfr-2 kinases |
| 01/20/2010 | CN101628898A Method for preparing N-aroyl-4-aryl-2-thiazolamines and intermediates of N-aroyl-4-aryl-2-thiazolamines |
| 01/20/2010 | CN100582098C Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (P T P 1 B) inhibitors for using as blood-sugar decreasing active ingredients for treating |
| 01/20/2010 | CN100581543C Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/19/2010 | US7649110 antidiabetic agents for treatment of type II diabetes |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 01/19/2010 | US7649007 Oxazolidine derivatives as PR modulators |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 01/19/2010 | CA2413000C Five-membered ring compounds |
| 01/19/2010 | CA2143135C Process for sulfinylating heterocyclic compounds |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/14/2010 | US20100010063 Heterocyclocarboxamide derivatives |
| 01/14/2010 | US20100010058 Azoline Compounds for Combating Arthropod Pests |
| 01/14/2010 | US20100010057 Thiazole derivatives as inhibitors of p13 kinase |
| 01/14/2010 | US20100010054 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/14/2010 | US20100009989 Urea Glucokinase Activators |
| 01/14/2010 | US20100009936 Chemical compounds |
| 01/14/2010 | US20100009935 Resistance-repellent retroviral protease inhibitors |
| 01/13/2010 | EP2142521A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | CN101627022A Heterocyclic compounds and heterocyclic polymers |
| 01/13/2010 | CN100579978C Compounds |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645783 Halogenated benzamide derivatives |
| 01/12/2010 | US7645782 Ethyl (2Z,5S,6E)-5-(tert-Butyl-dimethyl-silanyloxy)-2,6-dimethyl-7-(2-methyl-1,3-thiazol-4-yl)-hepta-2,6-dienoate; (3S)-3-(tert-Butyl-dimethyl-silanyloxy)-tetrahydrofuranone; breast , epidermoid, ovarian, lung, prostate cancer, cervix carcinoma, cancer of the bladder or leukemia |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645773 Thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2334618C Agents for combating plant pests |
| 01/07/2010 | WO2010002209A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 01/07/2010 | WO2010001922A1 Novel imino derivative, process for production of the same, and pesticide comprising the same |
| 01/07/2010 | WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 01/07/2010 | WO2009121535A3 Antiproliferative compounds and therapeutic uses thereof |
| 01/07/2010 | WO2009103432A3 Covalently binding imaging probes |
| 01/07/2010 | WO2009000533A8 Novel herbicides |
| 01/07/2010 | US20100004300 voltage-gated sodium channel inhibitors such as 4-[(3S,3'R)-3-(3,5-dichlorophenyl)-2'-oxo-1,3'-bipyrrolidin-1'-yl)]-N-(thiazol-2-yl)benzenesulfonamide, used for the treatment of neuropathic or inflammatory pain, arthritis, headaches, neuralgia, epilepsy, neurodegenerative or psychiatric disorders |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004297 Novel hexafluoroisopropanol derivatives |
| 01/07/2010 | US20100004292 Iminooxazolidine Derivatives and Their Use |
| 01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| 01/07/2010 | US20100004219 Modulators of glucocorticoid receptor, ap-1, and/or nf-kappabeta activity and use thereof |
| 01/07/2010 | US20100001635 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/07/2010 | CA2729557A1 Chemical compounds 251 |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/07/2010 | CA2729191A1 Novel imino derivatives, methods for producing the same and insecticides containing the same |
| 01/07/2010 | CA2728469A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/06/2010 | EP2140865A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
| 01/06/2010 | CN101622235A Novel process for synthesis of pramipexole and its pharmaceutically acceptable salts |
| 01/06/2010 | CN101619046A 5-methyl fluoride-2-phenylthiazole-4-ethyl formate and preparation method thereof |
| 01/06/2010 | CN100577163C Compounds effecting glucokinase |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642275 Histone deacetylase inhibitors |
| 01/05/2010 | US7642274 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326239 Fermentative preparation process for and crystal forms of cytostatics |
| 12/31/2009 | US20090326222 Benzothiazole cyclobutyl amine derivatives |
| 12/31/2009 | US20090326021 Thiazolo naphthyl acids |
| 12/31/2009 | US20090326020 Compounds for treatment of cancer |
| 12/31/2009 | US20090326018 2-Phenyl indene derivatives useful as estrogen receptor ligands |
| 12/31/2009 | US20090326012 Malononitrile Compounds |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325961 INDANE MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 12/31/2009 | US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 12/30/2009 | WO2009157528A1 Benzothiazole carboxamides as fungicides |
| 12/30/2009 | WO2009157527A1 Benzothiazole carboxamides as fungicides |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009157399A1 Sulfonamide compound or salt thereof |
| 12/30/2009 | WO2009157196A1 Amide compound |
| 12/30/2009 | WO2009156336A1 Sulfoximinamide compounds for combating animal pests |
| 12/30/2009 | WO2009120803A3 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 12/30/2009 | WO2008141234A3 Methods of making epothilones |